Skip to main content
SpringerLink
Log in

ALT test reduces LFT testing and costs of statin therapy

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Homer K, et al. Reducing liver function tests for statin monitoring: an observational comparison of two clinical commissioning groups. British Journal of General Practice : 30 Jan 2017. Available from: URL: https://doi.org/10.3399/bjgp17X689365

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

ALT test reduces LFT testing and costs of statin therapy. PharmacoEcon Outcomes News 771, 10 (2017). https://doi.org/10.1007/s40274-017-3721-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-3721-5

Search

Navigation